When should "chronic migraine" patients be considered "refractory" to pharmacological prophylaxis

被引:21
作者
D'Amico, Domenico [1 ]
Leone, Massimo [1 ]
Grazzi, Licia [1 ]
Bussone, Gennaro [1 ]
机构
[1] C Besta Neurol Inst, Dept Clin Neurosci, I-20133 Milan, Italy
关键词
chronic migraine (CM); refractory; prophylaxis;
D O I
10.1007/s10072-008-0888-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Patients with chronic headache forms evolving from a previous episodic migraine ('chronic migraine') are often difficult to treat. In this paper we focus attention on aspects we believe important for producing a definition of "refractory" in relation to this headache form. We propose a "chronic migraine" patient should be considered "refractory" to pharmacological prophylaxis when adequate trials of preventive therapies at adequate doses have failed to reduce headache frequency and improve headache-related disability and, in patients with medication overuse, reduce the consumption of symptomatic drugs. However before a definition of "refractory" chronic migraine can become established, generally accepted diagnostic criteria and treatment guidelines for this condition need to be developed.
引用
收藏
页码:S55 / S58
页数:4
相关论文
共 39 条
  • [1] Disability in chronic migraine with medication overuse: Treatment effects at 3 years
    Andrasik, Frank
    Grazzi, Licia
    Usai, Susanna
    D'Amico, Domenico
    Kass, Steven
    Bussone, Gennaro
    [J]. HEADACHE, 2007, 47 (09): : 1277 - 1281
  • [2] [Anonymous], WOLFFS HEADACHE OTHE
  • [3] Field testing alternative criteria for chronic migraine
    Bigal, ME
    Tepper, SJ
    Sheftell, FD
    Rapoport, AM
    Lipton, RB
    [J]. CEPHALALGIA, 2006, 26 (04) : 477 - 482
  • [4] Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes
    Bigal, ME
    Rapoport, AM
    Sheftell, FD
    Tepper, SJ
    Lipton, RB
    [J]. CEPHALALGIA, 2004, 24 (06) : 483 - 490
  • [5] Amitriptyline and dexamethasone combined treatment in drug-induced headache
    Bonuccelli, U
    Nuti, A
    Lucetti, C
    Pavese, N
    DellAgnello, G
    Muratorio, A
    [J]. CEPHALALGIA, 1996, 16 (03) : 197 - 200
  • [6] Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis: A double blind trial
    Bordini, CA
    Arruda, MA
    Ciciarelli, MC
    Special, JG
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 1997, 55 (3B) : 536 - 541
  • [7] Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment
    Cole, Jason C.
    Lin, Peggy
    Rupnow, Marcia F. T.
    [J]. QUALITY OF LIFE RESEARCH, 2007, 16 (07) : 1231 - 1237
  • [8] Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study
    Diener, H-C
    Bussone, G.
    Van Oene, J. C.
    Lahaye, M.
    Schwalen, S.
    Goadsby, P. J.
    [J]. CEPHALALGIA, 2007, 27 (07) : 814 - 823
  • [9] Medication-overuse headache: a worldwide problem
    Diener, HC
    Limmroth, V
    [J]. LANCET NEUROLOGY, 2004, 3 (08) : 475 - 483
  • [10] The impact of topiramate on health-related quality of life indicators in chronic migraine
    Dodick, David W.
    Silberstein, Stephen
    Saper, Joel
    Freitag, Fred G.
    Cady, Roger K.
    Rapoport, Alan M.
    Mathew, Ninan T.
    Hulihan, Joseph
    Crivera, Concetta
    Rupnow, Marcia F. T.
    Mao, Lian
    Finlayson, Gary
    Greenberg, Steven J.
    [J]. HEADACHE, 2007, 47 (10): : 1398 - 1408